IL1B and COVID-19: Given the propensity for systemic IL-1β, TNFα, and IL-6 to contribute to peripheral and central neuronal sensitization,11,52,94 it can be hypothesized that the increased prevalence of neurological manifestations seen in severe COVID-19 may be associated with elevations of these cytokines.